Algorithm with glucose monitor improves insulin dosing and boosts time in safe blood sugar range in type 2 diabetes.

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...

MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested ...

A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...

Leo, a 22-year-old man who received a diagnosis of type 1 diabetes at 17 years of age, has struggled to meet glucose targets. As a young adult, he has many competing priorities, and diabetes is not ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III QWINT development program found. In QWINT-1, there was a similar ...

Adults with type 1 diabetes had an increase in total daily insulin dose and bolus insulin dose shortly after stopping ...